“food-and-drug-administration” Archives

Entry Author Date Location
AtriCure to Buy Heart Device Developer nContact for $99M 10/05/15 Raleigh Durham
TransEnterix Acquires SOFAR Surgical Robotics Unit in $100M Deal 09/21/15 Raleigh Durham
Raleigh-Durham Roundup: Biotech Center, AvidExchange, Cempra, & More 09/21/15 Raleigh Durham
Alzheimer’s Drug Firm vTv Therapeutics Sets Terms for $125M IPO 07/20/15 Raleigh Durham
NephroGenex Aims to Raise $7.5M for Diabetic Nephropathy Drug 07/17/15 Raleigh Durham
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors 07/07/15 Detroit Ann Arbor
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
BioCryst Licenses Flu Drug to CSL, Gains Cash For Rare Disease Work 06/17/15 Raleigh Durham
How Pozen’s Tribute Pharma Deal Paves New Path for “Safer Aspirin” 06/16/15 Raleigh Durham
Leica Microsystems To Acquire Duke Eye-Imaging Spinoff Bioptigen 06/02/15 Raleigh Durham
NephroGenex Preps $30M Stock Offering to Expand Kidney Drug Trial 05/01/15 Raleigh Durham
Xbiotech’s $76M Offering Sets Course for Late-Stage Cancer Studies 04/15/15 Texas
HAP Innovations Tackles Missed Meds with Automated Dispenser 04/14/15 Raleigh Durham
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Allergen Takes $80M Series B for Phase 3 Peanut Allergy Trial 03/12/15 San Francisco
Heat Biologics Launches $10M Stock Offering; CFO To Move On 03/11/15 Raleigh Durham
DARA BioSciences Nabs U.S. Rights to Oral Thrush Drug 03/10/15 Raleigh Durham
Raleigh-Durham Roundup: MaxPoint, Targacept, Frontier Capital, & More 03/09/15 Raleigh Durham
Duke Cardiologist Califf Appointed FDA Deputy Commissioner 01/26/15 Raleigh Durham
Migraine Drug Developer CoLucid Lands $37.1M for Phase 3 Trial 01/13/15 Raleigh Durham
Cempra Antibiotic Hits Pneumonia Goals; $100M Stock Sale Planned 01/06/15 Raleigh Durham
How Ebola Drug Trials Today Could Shape Future Drug Development 12/09/14 Raleigh Durham
Pozen, Sanofi Terminate Drug Pact Ahead of FDA Approval Decision 12/01/14 Raleigh Durham
Raleigh-Durham Roundup: Appia, Chimerix, Ascletis & More 11/17/14 Raleigh Durham
Chimerix Plans $105M Stock Offering to Finance Ebola Drug Trials 10/30/14 Raleigh Durham
BioPontis, Reborn as Nonprofit, Takes On Rare Disease Drugs 10/20/14 Raleigh Durham
Chimerix Antiviral to Start in Ebola Clinical Trial 10/16/14 Raleigh Durham
Raleigh-Durham Roundup: Targacept, Chimerix, Red Hat, & More 10/13/14 Raleigh Durham
Orphan Drug From Scioderm Aims to Treat Rare Skin Disease 10/07/14 Raleigh Durham
Texas Ebola Patient Gets Chimerix Drug, Clinical Trials Planned 10/06/14 Raleigh Durham
Page 1 of 2 next page »